Table 2.
Univariate regression of potential predictors of the change in eGFR in patients switched from TDF to TAF
Variable | Coefficient (95% CI) | p value |
---|---|---|
Age | 0.120 (− 0.080 to 0.396) | 0.189 |
Cumulative TDF exposure | 0.025 (− 0.069 to 0.031) | 0.454 |
Pre-switch eGFR | − 0.381 (− 0.516 to − 0.247) | < 0.001 |
Pre-switch uPCR | 0.085 (− 0.194 to 0.153) | 0.814 |
Statistically significant p value is in italic
eGFR estimated glomerular filtration rate, TAF tenofovir alafenamide, TDF tenofovir disoproxil fumarate